CPhI South Korea
Korea positioned to be global biopharma powerhouse, says industry association
Stem cells and biosimilars are driving the Korean pharma market, according to the country’s Biomedicine Industry Association KoBIA.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs